Mount Sinai Health System

TCI Seminar Series: Christine M. Eischen, PhD | Targeting p53 Mutant Cancer with a Novel PROTAC | In-Person

Christine M. Eischen, PhD

Herbert A. Rosenthal, MD ’56 Professor of Cancer Research

Co-Leader, Immune Cell Regulation and Targeting Program, Sidney Kimmel Cancer Center

Co-Director, Blood Cancer Center of Excellence 

Thomas Jefferson University

Tuesday, April 4 at 12:00pm to 1:00pm